Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Catalent Inc (CTLT) USD0.01

Sell:$85.14 Buy:$85.17 Change: $0.38 (0.44%)
Market closed |  Prices as at close on 22 September 2020 | Switch to live prices |
Sell:$85.14
Buy:$85.17
Change: $0.38 (0.44%)
Market closed |  Prices as at close on 22 September 2020 | Switch to live prices |
Sell:$85.14
Buy:$85.17
Change: $0.38 (0.44%)
Market closed |  Prices as at close on 22 September 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.

Contact details

Address:
14 Schoolhouse Rd
SOMERSET
08873-1213
United States
Telephone:
+1 (732) 5376200
Website:
https://www.catalent.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CTLT
ISIN:
US1488061029
Market cap:
$13.93 billion
Shares in issue:
164.14 million
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • John Chiminski
    Chairman of the Board, Chief Executive Officer
  • Alessandro Maselli
    President, Chief Operating Officer
  • Wetteny Joseph
    Chief Financial Officer, Senior Vice President
  • Jonathan Arnold
    President - Oral Drug Delivery Solutions
  • Manja Boerman
    President - Cell & Gene Therapy
  • Peter Buzy
    Chairman - Gene Therapy
  • Karen Flynn
    President - Biologics and Chief Commercial Officer
  • Mario Gargiulo
    Region President, Biologics – Europe
  • Aristippos Gennadios
    President - Softgel Technologies
  • Ricci Whitlow
    President - Clinical Supply Services

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.